51.   Four of its brand name medicines recently lost their patent protection, causing sales to decline swiftly as generic companies began selling lower-priced versions.

52.   Generics not found in the United States are available here, where patent protections expire more quickly.

53.   Generic drugs are lower-priced versions of brand-name drugs that have lost patent protection.

54.   Generic companies are restricted from copying a drug formula and selling it more cheaply as long as it enjoys patent protection.

55.   Generics are prescription drugs that have lost patent protection.

56.   Gerber noted that profits had been weak throughout the generic drug industry, which produces lower-priced versions of prescription drugs that have lost patent protection.

57.   GATT extended patent protections for as long as three years beyond the levels previously allowed by U.S. law.

58.   Generic drugs are lower-priced copies of existing branded drugs that have lost patent protection.

59.   Generic drugs, which can be sold once a drug loses patent protection, are lower-price copies of branded medications.

60.   Glaxo lost patent protection for Zantac in its biggest market, the U.S., in July and immediately generic competitors entered the market.